Wockhardt Limited announced the appointment of Deepak Madnani as Chief Financial Officer of the company, with effect from June 7, 2022. He succeeds Pramod Gupta, who has resigned from the role of CFO due to health reasons.
According to the company’s exchange filing, “The Board of Directors of the Company at its meeting held today i.e. 7 th June, 2022, took note of the same and approved the appointment of Mr. Deepak Madnani as the Chief Financial Officer of the Company with immediate effect.”
Deepak has nearly 22 years of leadership experience in Financial Operations covering Financial Reporting, Budgeting & Forecasting, Cash Flow Management, MIS Reporting, Auditing and Statutory Compliance with Proven abilities in leading implementation of systems/ procedures to achieve financial discipline and enhance process efficiency.
He has been associated with Wockhardt in various leadership positions within the Finance role for more than a decade. Prior to joining Wockhardt, he was associated in finance roles with Companies like Lifestyle Retail, Spencers.
He is a Commerce Graduate and holds a Masters’ Degree in Financial Management.
Wockhardt Ltd. is a global pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.